Pharma Marketing Blog Highlights
14 September 2007
Dear Raquelle,
You are receiving this selected list of Pharma Marketing Blog posts because you are subscribed to Pharma Marketing News or are a member of a related list. See the end of this message for more information.
The following list of topics is a sampling of posts made to Pharma Marketing Blog in the past month. Access this page online at:
http://www.blog.pharma-mkting.com/PMBlogHighlights.htm
ADVERTISEMENT
CONTENTS
FEATURED POST:
An Innovative System for Communicating Drug Risks to Patients
| An Innovative System for Communicating Drug Risks to Patients |
Anyone who has tried reading a drug label knows how difficult it is to understand. It is especially difficult for consumers and patients to understand and evaluate the potential risks associated with the use of Rx drugs.
A new study in the September 10 issue of the Archives of Internal Medicine found multiple problems with drug labels. The authors suggest that one way to improve readability and patient understanding of labels is for FDA to initiate a national standard for their format and content -- much like it did with the "Nutrition Facts" labels required on food packaging.
In fact, the FDA recently invited food companies, trade groups, watchdog organizations, medical experts and its overseas counterparts to share how front-label symbols, like the "traffic light" system used in Britain, can improve public health. Shouldn't the FDA champion a similar system to rate risks on drug labels?
It may be a cold day in Hell before the FDA gets around to even suggesting such a system for Rx drug labels.
Thankfully, however, the private sector is jumping in to fill the void!
iGuard, an organization initially funded by Quintiles Transnational, a contract research organization that manages clinical trials for drug companies, has developed a color-coded drug risk rating system.
For more on this, see:
http://pharmamkting.blogspot.com/2007/09/innovative-system-for-communicating.html
| Do Pharma Marketers Need a Thick Skin or Will a Thick Skull Suffice? |
Every Friday, I look forward to receiving "DTC In Perspective," Bob Ehrlich's weekly opinion piece.
Last Friday, Bob gave his "guidelines" for reviewing DTC (direct-to-consumer) marketing tactics and ads in an article called "DTC Critics." He suggested that because there will be many critics out there, including some who call for the firing of specific marketers, that "It takes a thicker skin to be a good marketer."
I respond to some of Bob' points, especially regarding DTC marketing ROI and whether or not DTC critics should include ROI estimates in their analysis.
Personally, I feel that some DTC marketers heads get too big in response to all the talk about how "creative" they are. This just might lead to skull thickening, which is known to squeeze your brains and not allow any NEW ideas in! I can understand developing a thick skin, but I have no patience with thick skulls.
For more on this, see:
http://pharmamkting.blogspot.com/2007/09/do-pharma-marketers-need-thick-skin-or.html
| Meet Dr. Andree Bates, Marketing ROI Expert |
Dr. Andree K. Bates, President, Eularis, is a leading expert in pharmaceutical marketing analytics. Her career has encompassed academic, clinical and pharmaceutical positions around the globe, and she has gained worldwide recognition within the healthcare industry for ROI and marketing effectiveness measures.
I am very pleased that Dr. Bates was my guest on a recent Pharma Marketing Talk podcast:
You Want Marketing ROI? You're Not Ready to Measure ROI!
If You Can't Define It, You Can't Measure It!
Listen to the audio archive here:
http://www.blogtalkradio.com/hostpage.aspx?show_id=95073
For more on this, see:
http://pharmamkting.blogspot.com/2007/09/meet-dr-andree-bates-marketing-roi.html
| Web 2.0: The New WILD, WILD WEST of the Internet! |
I am sick and tired of excuses from pharmaceutical companies who, when caught anonymously altering Wikipedia entries about their products, blame "overzealous vendors."
Overzealous vendors or not, pharmaceutical marketers are having a field day pushing the envelope on the Internet and especially in the social networking, Web 2.0 arena -- the new WILD, WILD WEST of the Internet.
Marketing Banditos are out there taking advantage of the system editing content, making comments to blogs disguised as common consumers, designing Google Adwords that flaunt FDA regulations.
For more on this, see:
http://pharmamkting.blogspot.com/2007/08/web-20-new-wild-wild-west-of-internet.html
| Rozerem's Cheapskate Sweepstakes Violates Children's Online Privacy Protection Act |
Desperate times call for desperate measures.
Takeda needs to find another selling point that it can promote and now has turned to some old-fashioned market research to find the answers.
Hence, the Rozerem Sweepstakes, where you can win "cool prizes" -- NO PURCHASE NECESSARY!
But there are a couple of problems with this campaign..
For more on this, see:
http://pharmamkting.blogspot.com/2007/08/rozerems-cheapskate-sweepstakes.html
| J&J Lawyers Go Wild; PR on Vacation! |
J&J's recent announcement that it is filing a civil suit against the American Red Cross (ARC) has been likened by some in the blogger world to "kicking babies."
The sad fact is, no matter what the legal basis for this action is, J&J has allowed its legal department to outweigh its good public relations by acting independently and seemingly catching the J&J corporate communications department off-guard and on vacation.
For more on this, see:
http://pharmamkting.blogspot.com/2007/08/j-lawyers-go-wild-pr-on-vacation.html
###
Pharma Marketing Blog Update is published by:
VirSci Corporation
PO Box 760
Newtown, PA 18940-0760
infovirsci@virsci.com.
PHARMA MARKETING BLOG
These are the personal opinions of John Mack,Publisher and Editor of Pharma Marketing News. The views expressed on Pharma Marketing Blog do not necessarily represent the opinions of Pharma Marketing News, its advisory board or contributing authors. Read the newsletter for a more unbiased presentation of facts, product reviews and coverage of pharma industry conferences -- all based upon interviews with experts in the field of pharmaceutical marketing.
Send your comments to John Mack at 215-504-4164, johnmack@virsci.com.
CHANGING YOUR SUBSCRIPTION OPTIONS
If you wish to *** from Pharma Marketing News, please click the "Safe***" button below. You can also send an email request to infovirsci@virsci.com.
© 2007. VirSci Corporation.
All rights reserved. Subscribers are encouraged to forward this e-mail, in its entirety, to their friends and colleagues.
|
|
|
|
Design Your Own Ad Campaign!
Pharma Marketing Network (PMN) is an exclusive business-to-business network for marketing and sales professionals in pharmaceutical companies, advertising agencies, consultant firms, and related businesses.
PMN offers a variety of advertising options including email blasts, banner ads, page ads, social networking, podcasts, advertorials, online listings, etc.
The most effective campaign combines several of these elements and there are several PMN ad packages that can meet your needs and save you a lot of dough through package discounts!
Our Rate Card can give you an idea of the packages available, but mow you can design your own package simply by answering a few questions in our NEW Design Your Ad Package Tool!
By answering a few questions in this form, you will get access to the latest Rate Card AND also get a quote on a promotional campaign package designed to meet your specific needs.
If you are promoting an Event (conference, webinar, etc.), a Product or service, or a Job opening, there is a package for you! Find out more: Design Your Ad Package Tool.
After answering a few short questions about your specific needs you can get a quote for a package designed specifically for you. You will also get our latest Rate Card.
NOTE: You can always customize your quote afterward!
Other People's Opinion
A bi-weekly podcast. Listen and call-in live online or download to your iPod! Find out more here
(http://www.talk.pharma-mkting.com),
including links to upcoming shows.
ePharma Marketing
A New Addition to the Pharma Marketing News Archives!
OVERVIEW
eMarketing is a challenge for the pharmaceutical industry. As evidence, I need only point out that the percent of the pharmaceutical marketing budget spent in the "e" space has remained below 5% since the dawn of the commercial Internet!
Many experts, however, believe that pharma eMarketing is at a tipping point and that pharmaceutical companies are poised to shift substantial ad spending from TV and other media to the Internet.
Although online media haven't offered the reach numbers that are possible with TV, it does offer other advantages such as depth of information, interaction and superior customer engagement.
The selection of articles in this
Special Supplement was chosen to give you a better perspective on pharma eMarketing and offers some useful case studies.
48 pages... Table of Contents
Order and pay for this Special Supplement online now using your credit card. PDF file delivered to you by email (usually within minutes of placing your order).
ONLY $29.95
ORDER NOW!
eDetailing
OVERVIEW
This Special Supplement to Pharma Marketing News brings together in one convenient document several topics and case studies on eDetailing and ePromotion to physicians.
The resultant collective wisdom of many experts both inside pharmaceutical companies and outside provide a frank assessment of the role and impact of eDetailing on physician marketing as well as the challenges that lie ahead.
Bonus Reprints Included:
22 pages... Table of Contents
Order and pay for this Special Supplement now using your credit card
ONLY $19.95 - SAVE $10!
PDF file delivered to you by email (usually within minutes of placing your order):
ORDER NOW!
|
Back to newsletter list
